VenOx27 Lifetime Achievement Award
Professor Maria Elena de Lima, PhD
Full Professor: Universidade Federal de Minas Gerais (UFMG), Brazil
Professor/Researcher: Faculdade de Saúde Santa Casa de Belo Horizonte – Graduate Program in Medicine and Biomedicine
Lattes CV: http://lattes.cnpq.br/5642915270924367
Emails: lima.mariaelena@gmail.com | mariaelena@faculdadesantacasabh.edu.br | melenalima@icb.ufmg.br
Education
PhD Neurosciences, Marseille University, France (1985-1988) and Postdoctoral fellowship in the laboratory of Prof. Dr. Hervé Rochat);
MSc Biochemistry & Immunology, Universidade Federal de Minas Gerais – UFMG (1982; Supervisor: Carlos Ribeiro Diniz)
BSc Biological Sciences, Universidade Federal de Uberlândia
Scientific Profile and Main Contribution
Internationally recognized toxinologist working at the interface of venom biochemistry, pharmacology and translational drug discovery. Her research explores bioactive peptides from Phoneutria nigriventer, Lycosa erythrognatha and other venomous animals presenting pro-erectile, antinociceptive, anti-glaucoma, antimicrobial, insecticidal and anticancer activities.
Major results are:
- The pharmacological characterization of the neurotoxin PnTx2-6 (2008),
- the demonstration that it has a powerful erectile activity which is due to its activity slowing down the inactivation of the sodium channel and nitric oxide signaling,
- the demonstration that the biological function of PnTx2-6 is reproduced by a portion of the molecule dubbed PnPP-19,
- the demonstration that PnPP-19 does not have the toxic activities of the protein PnTx2-6 and doesn´t act on sodium channels.
- The synthetic peptide PnPP-19 is the non-toxic pharmacophoric part that activates the NO/cGMP pathway independently of sodium channels and without affecting blood pressure. It showed efficacy in normotensive, hypertensive, aged and diabetic models and is active by tophical application.
This last finding was published in Journal of Urology (2015) and highlighted in Nature Reviews Urology, and reported in sevral North European magazione and in The New York Times, among others.
The peptide was licensed to Biozeus biopharmaceuticalsn(https://biozeus.com.br/), originating the drug BZ371-A, with clinical safety and efficacy demonstrated in men and women; topical formulations are progressing toward Phase III trials for women and men. Additional actions include antinociceptive and anti-glaucoma effects via nitric oxide signaling. This represents a rare successful translation from venom molecule to advanced clinical candidate.
In addition, I had made several important contributions to the field of animal toxinology. These include the identification of novel hypotensive components in scorpion venoms and the first demonstration that the insect voltage-gated sodium channel (Nav) is composed of a single subunit, using scorpion toxins as molecular probes. I have also characterized proteases and neurotoxic phospholipases A₂ from snake venoms, expanding the biochemical understanding of these toxins.
My work further encompasses the isolation/synthesis and mechanistic investigation of peptides from Lycosa erythrognatha with potent antimicrobial and anticancer activities. I have conducted pharmacological studies of analgesic toxins from Phoneutria nigriventer and designed smaller optimized peptides that retain strong analgesic efficacy. Additional studies involving scorpionfish venoms, frog skin secretions, and bee venom further broaden the scope and biomedical relevance of my toxinological research.
Selected Papers in Biotechnological Research
Nunes et al.; de Lima ME. Tx2-6 toxin of the Phoneutria nigriventer spider potentiates erectile function. Toxicon (2008). https://doi.org/10.1016/j.toxicon.2008.02.010
de Lima ME et al. Toxinology in Brazil: a big challenge for a rich biodiversity. Toxicon (2010). https://doi.org/10.1016/j.toxicon.2010.05.005
Nunes et al.; de Lima ME. PnTx2-6 induces cavernosal relaxation via NO/cGMP signaling. International Journal of Impotence Research (2011). https://doi.org/10.1038/ijir.2011.47
Nunes et al.; de Lima ME. New insights on arthropod toxins that potentiate erectile function. Toxicon (2013) https://doi.org/10.1016/j.toxicon.2013.03.017
Almeida et al.; de Lima ME. Venoms and toxins from Brazilian fauna as sources for drug discovery. Acta Physiologica Sinica (2015). https://doi.org/10.13294/j.aps.2015.0033
Silva et al.; de Lima ME. PnPP-19, a synthetic and nontoxic peptide derived from a spider toxin, potentiates erectile function. Journal of Urology (2015). https://doi.org/10.1016/j.juro.2015.06.081
Freitas et al.; de Lima ME. PnPP-19 induces peripheral antinociception via opioid and cannabinoid mechanisms. British Journal of Pharmacology (2016). ***https://doi.org/10.1111/bph.13448 (see below in honors)
Almeida et al.; de Lima ME. Skin permeation of transfersomes containing the peptide PnPP-19. Current Drug Delivery (2018) https://doi.org/10.2174/1567201815666180108170206
Silva et al.; de Lima ME. PnPP-19 restores erectile function in hypertensive and diabetic animals. Journal of Sexual Medicine (2019) https://doi.org/10.1016/j.jsxm.2019.01.004
da Silva et al.; de Lima ME. PnPP-19 as a topical glaucoma drug candidate via nitric oxide release. Translational Vision Science & Technology (2020).https://doi.org/10.1167/tvst.9.8.33
Silva et al.; de Lima ME. PnPP-19 potentiates erectile function via nNOS and iNOS. Nitric Oxide – Biology and Chemistry (2021). https://doi.org/10.1016/j.niox.2021.04.007
LIMA, WILLIAM GUSTAVO et al; DE LIMA, MARIA ELENA DE. Highlighting the Potential of LyeTx I, a Peptide Derived from the Venom of the Spider Lycosa erythrognatha, as a Potential Prototype for the Development of a New Antimicrobial Against Carbapenem-Resistant Klebsiella pneumoniae. PHARMACEUTICALS, v. 18, p. 679, 2025. https://doi.org/10.3390/ph18050679
PINTO, BÁRBARA et al; DE LIMA, M.E. Toxin-Derived Peptides as Potentials Weapons Against Cancer. PHARMACEUTICS, v. 18, p. 722 (2026). https://doi.org/10.3390/pharmaceutics18060722
Scientific Production and Leadership
171 peer-reviewed articles
~25 international granted patents
Book´s editor: Animal Toxins: State of the Art (UFMG, 2009); Spider Venoms (Springer, 2016)
Editor for special Issues: Frontiers in Biochemical Sci (2), JVATD (4), Toxins (2)
Technology transfer UFMG → Biozeus Biopharmaceuticals
At UFMG: Head of Biochemistry & Immunology Department; Coordinator of the Graduate Program in Biochemistry and Molecular Biology; President Human Research Ethics Committee; Dean of Research; University Council Member.
Member, International Society on Toxinology (IST)
President, Brazilian Society of Toxinology for two times (2006–2010);
Chair of the 2009 World Congress IST-SBTx in Recife (Brazil), Chair of the 2010 national Congress of SBTx in Araxá (Brazil)
Member, Brazilian Society of Biochemistry and Molecular Biology (SBBq)
Organization or Participation in Scientific Event Committees (19)
Supervised about 60 MSc/PhD students and ~12 postdoctoral fellows
Editorial Board: Toxicon, Toxins, Frontiers in Cellular Biochemistry, Journal of Venomous Animals and Toxins Including Tropical Diseases (Associate Editor)
Honors:
Redi Award – IST (2026) – in the XXIII Congress of the IST – Manaus- Brazil
International — Toxins Award (2022); Awarded by the Journal “Toxins” (MDPI) for research on Phoneutria venom. International Congress of Venomous Animals in Roraima – I VenoRaima
Article selected among the best recent research from Latin America published in the British Pharmacological Society journals (2018)
Prize of the best thesis in Biochemistry, UFMG (2018) – as advisor of Carolina Nunes
2019 Champions of Science Storytelling Challenge – Latin America and the Caribbean Edition, Johnson & Johnson/UNESCO-cerimony (2019)
Research Highlight Nature Reviews Urology (2015)
Ananteris mariaelenae species named in her honor (1999) Brazil — CONFAP Award in Science & Innovation (2025)
Santos Dumont Medal (1997)
Invited Lectures — Selected International
2026 –Redi award lecture – Spider peptides inspiring innovative therapeutics.
2025 -I International Congress Experimental Pathology- Challenges and Opportunities for Translational Health Research
2024 -International Meeting on Animal Venom Peptides- Mining therapeutic drugs in spider peptides
2023 -XVII SBTx / XIII Pan-American IST-Spider venoms inspiring new medicines; Tribute to Hervé Rochat
2022 -VENORAIMA –PnPP-19 for erectile dysfunction and glaucoma
2019- 20th World Congress IST-Antimicrobial peptides from Lycosa erythrognatha venom
2016 -XII Pan-American IST-PnPP-19 drug candidate
2015 -World Congress Animal, Plant & Microbial Toxins; IUBMB- Synthetic peptides derived from the toxin Lyetxi of the Lycosa erythrognatha spider venom are potent antibiotics
2014 -Asia-Pacific Toxins- Unraverling Biological Activities of a toxin from the Spider P. nigriventer
2013 -Pan-American Toxinology- Spider toxins: exploring new peptides as possible drug models
2012 -17th World Congress IST- Biological activities of PnTx2-6, an exciting toxin from P. nigriventer
2009 -16th World Congress IST- Chair; President SBTx
2010 -Congress SBTx – Chair; President SBTx
2006 – UNESCO Consultation on Codes of Conduct for Scientists
2005 -Hispano-Brazilian Scientific Meeting- Studies of Isolated Compounds of Rheedia brasiliensis P
2004- Pan-American IST Symposium – Exploring new molecules from spider venoms
2003 -Rencontres en Toxinologie- Mode d´action d´une puissante toxine insecticide of P. reidy
1987- Semiochemicals in Plant & Animal Kingdoms- Chemistry and mode of action of scorpion toxins







